Target intelligence / Profile preview

3-aminopropanal (3-AP) (3-AP)

Target
3-AP
Molecular classification
Other (Reactive aldehyde), Other (Metabolite), Other (Neurotoxin)
01

Overview

3-aminopropanal (3-AP) is a highly reactive aminoaldehyde generated as a byproduct of polyamine metabolism, specifically through the oxidation of spermine and spermidine by the enzyme polyamine oxidase (PAO) [PubChem CID 119611]. It is primarily recognized for its potent neurotoxic properties, playing a significant role in the pathogenesis of brain injury following cerebral ischemia and in neurodegenerative diseases such as Alzheimer's [PubMed: 9723013]. The molecule induces cellular damage by promoting oxidative stress, causing protein carbonylation, and triggering lysosomal membrane rupture, which leads to both apoptotic and necrotic cell death [PubMed: 16461336]. While 3-aminopropanal is not a therapeutic target in the form of a receptor or enzyme, it is a critical pathogenic mediator whose production is targeted for inhibition. Experimental strategies to mitigate its effects include the use of polyamine oxidase inhibitors like MDL-72527 or aldehyde scavengers like aminoguanidine to prevent the accumulation of this toxic metabolite [PubMed: 12127011].

Other names
3-aminopropionaldehydebeta-aminopropionaldehyde3-oxopropan-1-amine
02

Mechanism of action

Prevention of 3-aminopropanal formation via polyamine oxidase inhibition or direct chemical neutralization by aldehyde scavengers.

03

Biological functions

Polyamine catabolismInduction of oxidative stressProtein carbonylationApoptosis inductionCell deathOther
04

Disease associations

Neurodegenerative diseaseOther (Cerebral ischemia)Other (Stroke)Other (Traumatic brain injury)
05

Safety considerations

High chemical reactivityPotent neurotoxicityInduction of lysosomal ruptureNon-specific protein damage
06

Interacting drugs

MDL-72527 (Polyamine oxidase inhibitor)

1 more in the full profile.

07

Biomarkers

3-aminopropanal concentration in cerebrospinal fluidPolyamine oxidase (PAO) activity levels

Beyond the preview

Go deeper on 3-aminopropanal (3-AP) (3-AP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-aminopropanal (3-AP) (3-AP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call